Company profile

イノバセル株式会社

EDINET
E41318
Securities
504A
Industry
Pharmaceutical
Latest annual securities report
2026-03-26 Annual Securities Report PDF HTML
Latest financial report
2026-08-06 Semiannual Securities Report PDF HTML
Latest filing
—
Compare this company

Industry position

Pharmaceutical

View details
Profitability Very strong Based on ROE Current Top 0%
Financial strength Weak Based on Equity ratio Current Bottom 4%

Latest half-year results

H1 FY2026

2026/01/01 - 2026/06/30

Consolidated · Japanese GAAP · Cumulative YTD

Operating income was -¥1.42 billion, down 35.8% year over year. Net income was -¥1.64 billion, down 33.0% year over year.

Operating income -¥1.42B down 35.8% year over year
Net income -¥1.64B down 33.0% year over year
Operating cash flow -¥2.09B
Free cash flow -¥2.1B
Total assets ¥12.26B

Half-year trend

Half-year financial trend

H1 values are cumulative year-to-date.

H2 values are calculated when comparable.

Consolidated · Japanese GAAP · Cumulative YTD

Mode

Half-year financial data

Annual key financial indicators

FY2025

Consolidated Japanese GAAP

Operating income was -¥2.23 billion. Net income was -¥2.86 billion. ROE was 453.0%; equity ratio was -12.4%; free cash flow was -¥2.05 billion.

Revenue —
Operating income -¥2.23B
Net income -¥2.86B
Total assets¥5.09B
Total equity—
Operating cash flow-¥2B
Free cash flow-¥2.05B

Industry position details

Pharmaceutical

Annual data for the same fiscal year and industry

FY2025 Comparison sample 32

Profitability Very strong
Based on ROE

ROE Top 4%

Financial strength Weak
Based on Equity ratio

Equity ratio Bottom 100%

Profitability ROE 453.0% Industry median -29.2% Top 4%
Financial strength Equity ratio -12.4% Industry median 71.4% Bottom 100%

Annual financial data

Fiscal year Scope Accounting standard Revenue Operating income Ordinary income Profit before tax Net income Profit attributable to owners of parent Comprehensive income Total assets Total liabilities Net assets Shareholders' equity Equity Equity attributable to owners of parent Equity for ratio Operating cash flow Investing cash flow Financing cash flow Free cash flow Cash and cash equivalents Basic EPS P/E Share price Market cap Book value per share Dividend per share Shares issued Equity ratio Official equity ratio ROE ROA Operating margin Ordinary income margin Net margin Operating cash flow margin Free cash flow margin Dividend payout ratio Revenue YoY Operating income YoY Ordinary income YoY Profit before tax YoY Net income YoY Total assets YoY Equity YoY Operating cash flow YoY Investing cash flow YoY Financing cash flow YoY Free cash flow YoY Cash and cash equivalents YoY EPS YoY Dividend per share YoY Shares issued YoY Employees YoY Average salary YoY Employees Average salary
FY2025 Consolidated Japanese GAAP -2231686000 -2853829000 -2855124000 -2855124000 -3235602000 5092561000 5722816000 -630254000 -1901393000 -630254000 -1995296000 -53732000 4089625000 -2049028000 4101476000 -89.0 -78.95 33335702 -0.123759735 4.5301164292 -0.560646009 48

Source filings

Select a document type to load the filings list.

Select a filing type to load the list.

Document filter

Select filing types

Choose the filing types to display.

Filing types containing financial data are selected by default.

Source data: Financial Services Agency EDINET / Data organization, aggregation, and metric calculations: bestforever.jp